Results 131 to 140 of about 41,952 (292)
Steps to Better Kidney Health for People with Sickle Cell Disease [PDF]
People with sickle cell disease (SCD) are at greater risk than the general population for kidney complications. Share your medical history with your healthcare team so it can properly identify and treat any complications of SCD you currently have or may ...
core
Engineering Reports, Volume 8, Issue 6, June 2026.This systematic review traces the evolution of protein function prediction from experimental methods through homology‐based tools, ML and DL to XAI. While deep learning models achieve state‐of‐the‐art predictive accuracy, their black‐box nature limits biological insight and clinical trust.
Aastha Katiyar, Rashmi Yadav
wiley +1 more source
Food Chemistry International, Volume 2, Issue 2, Page 246-262, June 2026.After collecting Musa paradisiaca leaves, some were dried and others were used to produce aqueous extracts. The extracts and powders were characterized and then administered to rats made anaemic by PHZ. After 14 days of administration of the two samples, the rats were euthanized and it was observed that after 9 days of treatment, the aqueous extract ...
Josée Rebeca Nombo +8 more
wiley +1 more source
Interview with Edward Bynum - OH 322
, 1984 This collection includes an interview of Edward Bynum (1933-2012) concerning his work with the Dr. James R. Clark Memorial Sickle Cell Anemia Foundation.
Bynum, Edward +1 more
core
HemaSphere, Volume 10, Issue 6, June 2026.Abstract Thalassemia and sickle cell disease (SCD) are among the most common monogenic disorders worldwide. They cause chronic hemolytic anemia, the consequences and prognosis of which vary considerably depending on the genetic characteristics of patients and the healthcare system in their country of residence.
Mariane de Montalembert +19 more
wiley +1 more source
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)
core
HemaSphere, Volume 10, Issue 6, June 2026.Abstract Patients with paroxysmal nocturnal hemoglobinuria (PNH) on anti‐C5 often experience extravascular hemolysis with anemia. Iptacopan, the first oral proximal complement inhibitor targeting factor B, has shown efficacy and safety in PNH patients. APPULSE‐PNH (NCT05630001), a phase 3b, single‑arm, open‐label trial, enrolled adult patients with PNH
Austin Kulasekararaj +31 more
wiley +1 more source
Mission: To improve quality of life, life expectancy, and health among people living with sickle cell disease (SCD)
core
Oral Radiographic Changes in Severe Sickle Cell Anemia Patients: A Retrospective Comparative Study. [PDF]
Clin Cosmet Investig DentAlKhodier H +3 more
europepmc +1 more source
G‐CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution
American Journal of Hematology, Volume 101, Issue 6, Page 1178-1181, June 2026.
Akshay Sharma +17 more
wiley +1 more source